BioSpace News Archive

Access Vascular, Inc. has been awarded a group purchasing agreement for a Breakthrough Technology contract with Premier. Effective September 1, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the HydroPICC™ peripherally inserted central catheter which is indicated for reduced thrombus accumulation

Zoetis Inc. announced that the European Commission has granted marketing authorisation for Simparica Trio™ chewable tablets, a once-monthly triple combination antiparasitic medication for dogs with, or at risk from, mixed external and internal parasitic infestations.

Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced an anticipated substantial increase in sales in Q4 2019 coming from its first hemp harvest now underway

Delos Capital today announces that it has launched Curamir Therapeutics Inc., a Woburn, MA-based biotechnology company pioneering micro RNA (miRNA) based cancer therapeutics, with a $10 million Series A financing.

Oppenheimer & Co. Inc. (“Oppenheimer”) – a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) – will host its two-day Fall Summit Focused on Specialty Pharma and Rare Disease Companies on September 23-24, 2019 in New York.

BioPharmX Corporation, a specialty pharmaceutical company focused on developing innovative medical dermatology products, received a notice on September 19, 2019 from the NYSE American LLC granting the Company an extension until March 24, 2020 to regain compliance with certain NYSE American continued listing standards related to its stockholders’ equity balance.

Encompass Health Corporation (NYSE: EHC) today issued notice for redemption of $400 million of the outstanding principal balance of its 5.75% senior notes due 2024 (the “2024 Notes”).

MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or “the Company”), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that Luis A. Aguilar has notified the Company of his resignation from the Board of Directors

95% of surgeons have either been personally affected by a needlestick injury or have seen a colleague experience one, increasing the risk of infection, a new global survey of surgeons has found.

Vizient, Inc. today announced the winners of their Bernard A. Birnbaum, MD, Quality Leadership Award and Ambulatory Care Quality and Accountability Award for 2019.